GeneNews partner readying ColonSentry submission

Enzo Biochem’s (NYSE:ENZ) clinical labs division has completed validation testing of the GeneNews (TSX:GEN) ColonSentry pre-screening test for colorectal cancer and is in the final stages of submitting the data package to New York State regulatory authorities, according to a new report by Rodman & Renshaw. Analyst Reni Benjamin writes that the validation “demonstrated consistency [...]

TearLab in marketing pact with Abbott Medical Optics

TearLab (NASDAQ:TEAR; TSX:TLB) has entered into a cooperative marketing agreement with Abbott Medical Optics’ (NYSE:ABT) Canadian subsidiary, AMO Canada. Under the accord, AMO will distribute TearLab’s Osmolarity System in Canada while TearLab will help promote AMO Canada’s products for the relief of dry eye symptoms, including Blink Moisturizing Eye Drops.  Financial terms weren’t disclosed. “Assessment of [...]

In conversation with Matt Buist

Matt Buist was recently named an “Outstanding Canadian Business Leader in the Life Sciences” by the Canadian Biotechnology handbook.  And it’s no wonder.  After 15 years as the day-to-day coordinator of the Toronto Biotechnology Initiative (BTI) and, more recently, Life Sciences Ontario (LSO) through his role as manager of business development, medical and biotechnology, for [...]

IntelGenx in commercialization pact with RedHill

IntelGenx (TSX-V:IGX) has entered into a co-development and commercialization agreement with RedHill Biopharma of Israel to develop IntelGenx’s first product from its VersaFilm technology for rapid relief of migraine. Under the accord, RedHill has obtained certain exclusive worldwide rights to market and sell IntelGenx’ rapidly dissolving anti-migraine oral film product. In exchange, IntelGenx will receive [...]

New fund for Ontario biotech companies

Ontario’s Ministry of Research and Innovation has launched the next initiative under its $161-million Life Sciences Commercialization Strategy, with a one-time $7 million fund to help early-stage, Ontario-based biotech companies get the financing they need to grow.  The program is being delivered in connection with the Ontario government’s existing Investment Accelerator Fund program, which is administered by MaRS. Program [...]

Bioniche licenses botanicals from University of Ottawa

Bioniche Life Sciences (TSX:BNC) and the University of Ottawa have signed an exclusive global licence agreement that gives Bioniche commercial access to the university’s technology for natural health botanical therapeutics and pharmaceutical compounds for treating anxiety and related conditions in animals, humans and aquaculture. University of Ottawa researchers and collaborators at the Universidad Nacional in Costa [...]

Study backs ColonSentry effectiveness

GeneNews (TSX: GEN) says that a poster describing a 786-patient study entitled “Blood RNA Biomarker Detects Both Left- and Right-sided Colorectal Neoplasms” has been accepted for presentation at the Next Generation Dx Summit in Washington, DC this week. The poster details the application of a seven-gene biomarker panel, which forms the basis of the company’s [...]

Isotechnika and 3SBio ink licence deal

Isotechnika Pharma (TSX:ISA) and 3SBio, Inc., a Chinese biotechnology company, have signed a development and commercialization agreement for Isotechnika’s voclosporin drug to prevent organ rejection following transplantation and to treat autoimmune diseases. Under the accord, Isotechnika will receive $6 million (U.S.), consisting of an upfront licensing payment of $1.5 million and an additional $4.5 million [...]

Immunotec names Henry as chairman

Immunotec (TSX-V:IMM) has appointed one of its directors, Robert Henry, as its new executive chairman of the board to replace Alex Konigsberg, who passed away earlier this month. “One of my top priorities will be to assist management in pursuing growth opportunities both in the U.S. and internationally, especially in today’s challenging economic conditions,” Mr. [...]

DiagnoCure retains JMP Securities

DiagnoCure (TSX:CUR) has retained financial advisors JMP Securities to assist in determining the best option to drive the growth of its U.S.-based subsidiary, DiagnoCure Oncology Laboratories. “We are very excited to be partnering with JMP, and we are confident that their expertise will help us determine the most effective method to roll out our colorectal [...]

Next Page »